S. Oh

Toxic amebic colitis coexisting with intestinal tuberculosis.

H. Jeon, E. K. Kim, E. J. Lee, 2000, Journal of Korean medical science.

Laparoscopy in the management of gastric submucosal tumors

Y. B. Choi, S. Oh, S. Oh, 2000, Surgical Endoscopy.

Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer.

S. H. Lee, M. Shin, W. Park, 1999, Cancer research.

A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer.

S. H. Lee, M. Shin, S. Han, 2000, Cancer research.

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

B. K. Park, S. Jang, Y. Min, 2013, British Journal of Cancer.

LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

A. Tefferi, J. Gotlib, A. Pardanani, 2010, Leukemia.

A phase II study of paclitaxel and capecitabine combination chemotherapy in patients with advanced gastric cancer as a first-line therapy

J. Yook, M. Ryu, B. Kim, 2004 .

Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.

T. Kim, J. Yook, B. Kim, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

J. Yook, M. Ryu, J. Lee, 2008, British Journal of Cancer.

Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer.

H. K. Yang, O. Kwon, J. P. Kim, 1992, Annals of surgery.